AGC Biologics A/S

Form 483 issued May 10, 2021 · Soeborg, Denmark

Inspection
May 3 – May 10, 2021
Observations
2
Pages
1
FEI number
3004708748

In short: On May 10, 2021, FDA issued a Form 483 with 2 observations to AGC Biologics A/S in Soeborg, Denmark (FEI 3004708748) after an inspection that ran May 3 – May 10, 2021. The investigators were Michael R. Shanks and Zhenzhen Liu. Most observations concern quality system; the most-cited regulation is 21 CFR 211.25 (personnel qualifications).

At a glance

Observations span 1 system, led by quality system.

Quality system1
Other1

Most cited: 21 CFR 211.25 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Failure to assure that personnel have the necessary training in sample handling…

  2. 02

    Change control regarding test method documents updates is not implemented in a timely manner to avoid…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at AGC Biologics A/S?

FDA listed 2 observations on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.25 (personnel qualifications). The opening words of each observation are shown on this page.

Who inspected AGC Biologics A/S?

Michael R. Shanks and Zhenzhen Liu are named on this Form 483, for the inspection of May 3 – May 10, 2021. Each investigator has a profile showing what they cite most.

When was AGC Biologics A/S inspected by FDA?

The inspection ran May 3 – May 10, 2021, and the Form 483 is dated May 10, 2021.

How do I get the full Form 483 for AGC Biologics A/S?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free